-
Report: Don't entrust healthcare savings to patients older than 40
NEW YORK — Those older than 40 years may be making a negative impact on the future of the U.S. economy with the way they eat, live and keep track of their health, according to a white paper released Wednesday by the MetLife Mature Market Institute and co-authored by the Center for Healthy Aging.
-
FDA approves first new morning sickness pill in 30 years
ROSEMONT, Pa. — The Food and Drug Administration has approved a drug for treating nausea and vomiting during pregnancy.
Drug maker Duchesnay USA said the FDA approved Diclegis (doxylamine succinate and pyridoxine hydrochloride) delayed-release tablets in the 10 mg/10 mg strength for NVP, more commonly known as morning sickness, in women who don't respond to conservative treatment. NVP is estimated to affect 70-85% of pregnant women, and symptoms range from nausea to severe vomiting and retching that can last throughout the day.